Floatz logo

Alogliptin

Diabetes Mellitus

TakedaSmall moleculePhase 3Dormant
BBB
77/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
89/ 100

Competitive context

44 Active assets in the Diabetes Mellitus cohort.

Asset / SponsorPhaseRating
Metformin
Erbil Polytechnic University
Phase 4A
Pioglitazone
Milton S. Hershey Medical Center
Phase 4BBB
Glibenclamide
Takeda
Phase 4BBB
Acetylsalicylic Acid
Region Skane
Phase 4BBB
Sitagliptin
Second Affiliated Hospital of Soochow University
Phase 4BBB

View all 50 →

Same molecule, other indications

Alogliptin is also rated in:

type 2 diabetes mellitusDormant
BB
Indicative ·
69 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BB
Indicative ·
65 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →